Results 241 to 250 of about 199,652 (389)

Progressive systemic sclerosis - Report of two cases

open access: yesSRM Journal of Research in Dental Sciences, 2010
N Malathi   +4 more
doaj  

The Prevalence and Severity of Pain in Patients With Systemic Sclerosis

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT We investigated pain prevalence and severity in systemic sclerosis (SSc) and patient–physician perceptions. This was an internet‐based survey that compared perceptions of pain type, location, severity, associated factors between patients with SSc and physicians, and pain treatment prescription patterns in Japan in March 2023.
Sei‐ichiro Motegi   +6 more
wiley   +1 more source

IgG4‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets

open access: yesAllergy, EarlyView.
ABSTRACT IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses.
Louisa Tedesco   +8 more
wiley   +1 more source

A case of visceral leishmaniasis mimicking connective tissue disease

open access: yes
Rheumatology &Autoimmunity, EarlyView.
Yucui Li   +4 more
wiley   +1 more source

Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis

open access: yesBipolar Disorders, EarlyView.
ABSTRACT Background Recent advances now allow detection of brain‐specific proteins in blood, including neurofilament light chain (NfL), a marker of axonal pathology, and glial fibrillary acidic protein (GFAP), indicative of astrocytic activation. Given the evidence of astroglial pathology and neuronal dysfunction in bipolar disorder, and ongoing ...
Matthew J. Y. Kang   +15 more
wiley   +1 more source

Dexamethasone-cyclophosphamide pulse therapy in progressive systemic sclerosis

open access: yesIndian Journal of Dermatology, 2010
Viswanath Vishalakshi   +3 more
doaj  

CCR5 predicts neurotoxicity in CAR‐T‐cell therapy

open access: yesBritish Journal of Haematology, EarlyView.
Patients undergoing chimeric antigen receptor T (CAR T)‐cell therapy are at risk of developing immune effector cell‐associated neurotoxicity syndrome (ICANS). We observed an upregulation of CCR5 and CCR2 expression in CD4+ T cells among patients who developed ICANS.
Ayal Rozenberg   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy